Killick Capital, founded in 2004 and headquartered in St. John's, Newfoundland and Labrador, primarily invests in venture businesses, aerospace businesses, and Newfoundland & Labrador businesses. They typically invest in rounds with 2-3 participants and have been involved in less than 2 investment rounds annually. The fund has a preference for startups in the healthcare and energy industries, with notable portfolio companies including radient360, Sequence Bio, and Mysa. Killick Capital has a track record of committing exits more frequently than other organizations and has a particular interest in investing in startups that are 2-3 years old.